Indxx September Newsletter

Indxx September Newsletter

EXCITING NEWS ON THE HORIZON

Webinar Spotlight: Indxx at MFDF

Our President and Co-CEO, Rahul Sen Sharma, was featured in an MFDF webinar, where he discussed the basics of index construction, the significance of quality data, and more.

Click here to watch the session

Highlights from Independence Day Festivities

The Indxx family came together to celebrate India’s Independence Day, embracing the tricolor theme. From engaging games to delicious food, we had a memorable time.

?Click here to catch a glimpse

INDXX ITICS FACTOREDGE INDEX SERIES

The Indxx ITICS FactorEdge Index Series is an innovative range of indices that offer access to companies with superior fundamentals within specific themes, such as airlines, drug manufacturers, renewable energy, REITs and more.

In 2023, the Indxx ITICS Retail Banking Factor Edge Index_Factor Tilt outperformed the base index by 4.17%. Additionally, it has consistently delivered higher net interest margin compared to the base index.

Click here to learn more


Since their inception, both versions of the Indxx ITICS Semiconductor FactorEdge Index have delivered higher returns than the industry benchmark by significant margins.?

Click here to learn more

BLOG

Blockchain in Finance: A New Era of Financial Innovation

With its decentralized, secure, and transparent digital ledger, blockchain technology is transforming various sectors. Its immutable and distributed nature provides a robust foundation for numerous applications, from supply chain management to healthcare. In this blog, we will dive deeper into how blockchain is reshaping the finance industry…Continue Reading

FEATURED POSTS

CAdmin: Seamless Corporate Actions Management

CAdmin serves as a one-stop solution for all your corporate actions management needs. Here’s a look at a case study of the Indxx Blockchain Index.

Learn more

Samsung C&T: Through the ITICS Lens

Did you know that Samsung C&T Corporation, a South Korean construction & engineering company generates almost 9% of its revenue from Third Party Drug Manufacturing? This represents a large increase from just 1.57% in 2017.

Learn more

In case of any queries, write to us at [email protected]



要查看或添加评论,请登录

Indxx的更多文章

社区洞察

其他会员也浏览了